Somite.ai

AI-based Platform to Produce Human Tissue for Cell-based Therapies

Startup

Somite.ai is a startup in the Health Tech & Life Sciences sector, established in 2023. AI-based Platform to Produce Human Tissue for Cell-based Therapies. The company has raised a total of $57.5M across 3 funding rounds, currently at the A stage. Somite.ai was founded by Micha Breakstone, Olivier Pourquie, Jay Shendure, Allon Klein, Cliff Tabin, Jonathan Rosenfeld. Key investors include Khosla Ventures, Fusion Fund, Ajinomoto, among 16 total investors. The company has 11-50 employees. Core technologies: Artificial Intelligence.

With $57.5M in total funding, Somite.ai is a A-stage company operating in Health Tech & Life Sciences. The company follows a B2C business model. Product stage: R&D.

$57.5M
Raised
3
Rounds
16
Investors
7
Team
2023
Founded
Sector & Technology
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue EngineeringArtificial Intelligence
At a Glance
Investors

16 investors total

Founders
In the News

8 articles covered by sources including www.themarker.com, www.calcalistech.com, en.globes.co.il, www.forbes.com.

www.themarker.com · Jun 9, 2025
חברת Somite.ai בהובלת מדענים ישראלים מנסה לפתור בעיה שמעסיקה חוקרים כבר עשורים: איך לגרום לתא גזע להפוך בדיוק למה שצריך — ובקנה מידה תעשייתי. אם תצליח, תאים ביולוגיים יוכלו להחליף תרופות — ולשקם תפקודים שאבדו
Read article ↗
Frequently Asked Questions
What does Somite.ai do?

Somite.ai is aiming to become the OpenAI of stem cell biology, developing AI foundation models to produce human tissue for cell therapies at scale for diseases such as diabetes, obesity, and muscular dystrophies. Somite's AI platform, AlphaStem, fuels a virtuous cycle as it enables new cell therapies, generating massive data that further improve the platform, empowering even faster therapy creation with broader applications. The company's pipeline includes the promising SMT-M01 program for Duchenne muscular dystrophy (DMD) and the SMT-B01 program for metabolic disorders.

How much funding has Somite.ai raised?

Somite.ai has raised $57.5M in total funding across 3 rounds. The company is currently at the A stage. Key investors include Khosla Ventures, Fusion Fund, Ajinomoto.

Who founded Somite.ai?

Somite.ai was founded in 2023 by Micha Breakstone (Co-founder & CEO), Olivier Pourquie (Co-founder), Jay Shendure (Co-founder), Allon Klein (Co-founder), Cliff Tabin (Co-founder), Jonathan Rosenfeld (Co-founder & CTO).

What sector is Somite.ai in?

Somite.ai operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Biomaterials & Tissue Engineering, with core technologies in Artificial Intelligence. Target customers: Healthcare & Life Sciences, Life Sciences, Biotechnology.

Where is Somite.ai located?

Somite.ai is based in Israel. The company also has offices abroad.

View Full Profile Classic View Website ↗